top of page

New partners welcome – strategic expansion of PROXIDRUGS cluster in next funding round

Join a continuously expanding research-driven partnership focused on innovative therapies for human diseases.


Funded within the first round of the Clusters4Future initiative of the Federal Ministry of Education and Research (BMBF), the PROXIDRUGS cluster aims to develop new treatments for diseases with high unmet medical need by seizing proximity induction as versatile and innovative mode of drug action. Currently, five academic partners (Goethe University Frankfurt, TU Darmstadt, University of Heidelberg, the MPI of Biophysics, Fraunhofer Institute for Translational Medicine and Pharmacology) together with major pharma companies (AbbVie Deutschland, Merck Healthcare, GlaxoSmithKline, and Revvity as a technology provider) work together on eleven projects addressing a broad spectrum of research questions to improve this novel class of drugs in multiple ways.


We are now looking for new partners to expand our cluster for the second funding period. If you are interested in getting to know more about us and to find out how your company can actively join and complement this exciting research, contact us under: proxidrugs@uni-frankfurt.de


Comments


bottom of page